Lumexa Imaging

Q2 FY2026 EarningsQ2 FY26 reported mixed results with revenue of $264.2M (+0.40% vs. consensus) and a significant miss on GAAP EPS ($0.03 vs. $0.14 expected). While outpatient same-center revenue grew 2.2%, operating margins were pressured by a 30.5% YoY increase in G&A expenses due to post-IPO stock-based compensation. Interest expense decreased 46.1% YoY following a successful debt refinancing, yet a high effective tax rate of 52.4% further constrained bottom-line performance.